Article info

Download PDFPDF

Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

Authors

  1. Correspondence to Dr Sally Taylor; sally.taylor38{at}nhs.net
View Full Text

Citation

Taylor S, Yorke J, Tsim S, et al
Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

Publication history

  • Received November 25, 2020
  • Accepted June 15, 2021
  • First published July 15, 2021.
Online issue publication 
July 15, 2021

Related Data

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.